wada prohibited list bpc-157 tb-500 status 2025 Reminder: WADA's comes into force on 1 January Reminder: WADA's 2025 Prohibited List

BPC-157 has shown particular promise in gastrointestinal applications, while TB-500 has demonstrated potential cardiovascular benefits

TB-500 : 2 times weekly during the loading phase (4-8 weeks), then potentially once monthly for maintenance

The addition of Ipamorelin allows for deep investigation into selective receptor activation without influencing prolactin or cortisol levels, while CJC-1295 facilitates research into sustained GHRH-mediated pituitary signaling

Lauren Ashley

While they all aim to raise your levels, they differ in how they are produced and how long they stay active in your body

doi: 10.2147/NDT.S225643